Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 76

Sort by

Sort Order Select

Journal Articles

Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy

Blood (2022) 140 (3): 285–289.

https://doi.org/10.1182/blood.2022015832

Published: 2022

Includes: Supplemental data

Journal Articles

YAP and TAZ in Fibroblastic Reticular Cells Support Hematopoiesis and Retention of Lymphocytes in Lymph Nodes

Hyunsoo Cho, MD PhD, Yu Ri Kim, MD, Jieun Jang, MD, Haerim Chung, MD, Soo-Jeong Kim, Sung Yong Choi, Bae Hosung, Ralf Adams, Burkhard Ludewig, PhD, Jin Seok Kim, MD PhD, June-Won Cheong, MD PhD, Yoo Hong Min, MD PhD, Gou Young Koh

Blood (2019) 134 (Supplement_1): 3595.

https://doi.org/10.1182/blood-2019-124625

Published: 2019

Journal Articles

Peripheral Blood Absolute Lymphocyte Count at Diagnosis As a New Prognostic Factor in Acute Myeloid Leukemia with t(8;21) Patients

Jieun Jang, MD, Yu Ri Kim, MD, Hyunsoo Cho, MD PhD, Haerim Chung, MD, Soo-Jeong Kim, MD, Jin Seok Kim, MD PhD, June-Won Cheong, MD PhD, Yoo Hong Min, MD PhD

Blood (2019) 134 (Supplement_1): 5178.

https://doi.org/10.1182/blood-2019-128027

Published: 2019

Journal Articles

Results from a Global Randomized Phase 3 Study of Guadecitabine (G) Vs Treatment Choice (TC) in 815 Patients with Treatment Naïve (TN) AML Unfit for Intensive Chemotherapy (IC) ASTRAL-1 Study: Analysis By Number of Cycles

Blood (2019) 134 (Supplement_1): 2591.

https://doi.org/10.1182/blood-2019-127253

Published: 2019

Journal Articles

Progression Free Survival (PFS), and Event Free Survival (EFS) from a Global Randomized Phase 3 Study of Guadecitabine (G) Vs Treatment Choice (TC) in 815 Patients with Treatment Naïve (TN) AML Unfit for Intensive Chemotherapy (IC): ASTRAL-1 Study

Blood (2019) 134 (Supplement_1): 4235.

https://doi.org/10.1182/blood-2019-129614

Published: 2019

Journal Articles

Recovery of Specific Subsets of Natural Killer and T Cells Highly Associated with Graft-Versus-Host Disease after Haploidentical Stem Cell Transplantation in Acute Leukemia

Jieun Jang, MD, Haerim Chung, MD, Yu Ri Kim, MD, Hoi-kyung Jeung, Ju-In Eom, So-Young Seol, Soo-Jeong Kim, MD, Jin Seok Kim, MD, PhD, June-Won Cheong, MD PhD, Yoo Hong Min, MD PhD

Blood (2018) 132 (Supplement 1): 4581.

https://doi.org/10.1182/blood-2018-99-115786

Published: 2018

Journal Articles

Endoplasmic Reticulum Stress Signaling Comprises a G9a Inhibitor Tolerance Pathway and PERK Inhibition Increases Anti-Leukemia Activity of G9a Inhibitor in Leukemia Cells and Leukemia Stem-like Cells

Jieun Jang, MD, Ju-In Eom, Hoi-kyung Jeung, So-Young Seol, Haerim Chung, MD, Yu Ri Kim, MD, June-Won Cheong, MDPhD, Yoo Hong Min, MD PhD

Blood (2018) 132 (Supplement 1): 1360.

https://doi.org/10.1182/blood-2018-99-115814

Published: 2018

Journal Articles

Early CMV Replication-Associated Anti-Leukemia Effect Is Related to the Reconstitution of Specific Subsets of Natural Killer Cells after Haploidentical Stem Cell Transplantation in Acute Leukemia

Jieun Jang, MD, Haerim Chung, MD, Yu Ri Kim, MD, Hoi-kyung Jeung, Ju-In Eom, So-Young Seol, Soo-Jeong Kim, MD, Jin Seok Kim, MD, PhD, June-Won Cheong, MD PhD, Yoo Hong Min, MD PhD

Blood (2018) 132 (Supplement 1): 2128.

https://doi.org/10.1182/blood-2018-99-115733

Published: 2018

Journal Articles

Inhibition of Unc-51-like Kinase 1 (ULK1) with Novel Small Molecular Inhibitor MRT68921 Preferentially Induces Apoptosis and Autophagy in FLT3-ITD- Mutated Acute Myeloid Leukemia

Jieun Jang, MD, Hoi-kyung Jeung, So-Young Seol, Haerim Chung, MD, Yu Ri Kim, MD, June-Won Cheong, MD PhD, Yoo Hong Min, MD PhD

Blood (2018) 132 (Supplement 1): 3499.

https://doi.org/10.1182/blood-2018-99-115833

Published: 2018

Journal Articles

Clinical and Genetic Relevance of Somatic Mutations in Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) Patients Using Serial Sequencing

Taehyung Kim, MSc, Joon Ho Moon, MD, Jae-Sook Ahn, Marc S. Tyndel, Yeo-Kyeoung Kim, Seung-Shin Lee, MD, Seo-Yeon Ahn, Sung-Hoon Jung, MD, Deok-Hwan Yang, MD PhD, Je-Jung Lee, MD PhD, Seunghyun Choi, PhD, Yoojin Lee, MD, Sang Kyun Sohn, MDPhD, Yoo Hong Min, MD PhD, June-Won Cheong, MDPhD, Hyeoung-Joon Kim, Zhaolei Zhang, PhD, Dennis (Dong-Hwong) Kim, MD PhD

Blood (2017) 130 (Supplement 1): 3955.

https://doi.org/10.1182/blood.V130.Suppl_1.3955.3955

Published: 2017

Journal Articles

Prognostic Impact of Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome

Blood (2016) 128 (22): 5432.

https://doi.org/10.1182/blood.V128.22.5432.5432

Published: 2016

Journal Articles

The Clonal Origins of Leukemic Progression of Myelodysplasia

Taehyung Kim, MSc, Marc Tyndel, Hyeoung Joon Kim, MD, Jae-Sook Ahn, MD PhD, Seung Hyun Choi, PhD, Hee Jeong Park, Yeo-Kyeoung Kim, MD PhD, Deok-Hwan Yang, Je-Jung Lee, Sung-Hoon Jung, Soo Young Kim, Yoo-Hong Min, June-Won Cheong, MD, Sang Kyun Sohn, MD, PhD, Joon Ho Moon, MD, PhD, Murim Choi, Moses Lee, Zhaolei Zhang, PhD, Dennis Dong Hwan Kim, MD PhD

Blood (2016) 128 (22): 4307.

https://doi.org/10.1182/blood.V128.22.4307.4307

Published: 2016

Journal Articles

The Role of MYC and BCL-2 Double Expression the in DLBCL Patients with Advanced Stage and Elevated LDH Who Received Upfront ASCT after R-CHOP

Yu Ri Kim, Sun Och Yoon, Soo-Jeong Kim, MD, June-Won Cheong, MD, Hyewon Lee, MD, Haerim Chung, MD, Jung Yeon Lee, MD, Ji Eun Jang, MD, Yundeok Kim, MD, Woo-Ick Yang, Yoo-Hong Min, Jin Seok Kim, MD PhD

Blood (2016) 128 (22): 4219.

https://doi.org/10.1182/blood.V128.22.4219.4219

Published: 2016

Journal Articles

Pretreatment Whole Blood Epstein-Barr Viremia Is a Prognostic Factor in Peripheral T-Cell Lymphoma

Yu Ri Kim, Soo-Jeong Kim, MD, June-Won Cheong, MD, Hyewon Lee, Haerim Chung, MD, Jung Yeon Lee, MD, Ji Eun Jang, MD, Yundeok Kim, MD, Woo-Ick Yang, Yoo-Hong Min, Jin Seok Kim, MD PhD

Blood (2016) 128 (22): 4143.

https://doi.org/10.1182/blood.V128.22.4143.4143

Published: 2016

Journal Articles

Risk Factors for Cancer- and Catheter-Associated Thrombosis in Asian Patients with Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy

Hyunsung Park, MD, Hyunsoo Cho, MD, Jungyeon Lee, MD, Jieun Jang, MD, Yundeok Kim, MD, Soo Jeong Kim, MD, Yu Ri Kim, MD, PhD, June-Won Cheong, MD, PhD, Yoo Hong Min, MD,PhD, Jin Seok Kim, MD, PhD

Blood (2015) 126 (23): 1489.

https://doi.org/10.1182/blood.V126.23.1489.1489

Published: 2015

Journal Articles

The Prognostic Role of CD68 and FoxP3 Expression in Primary Central Nervous System Lymphoma

Soo-Jeong Kim, MD, Hyunsung Park, MD, Hyunsoo Cho, MD, Yu Ri Kim, MD, PhD, Jung Yeon Lee, MD, Ji Eun Jang, MD, Kim Yundeok, MD, June-Won Cheong, MD, PhD, Yoo Hong Min, MD,PhD, Jin Seok Kim, MD, PhD

Blood (2015) 126 (23): 1457.

https://doi.org/10.1182/blood.V126.23.1457.1457

Published: 2015

Journal Articles

Treatment Choice of Decitabine Versus Conventional Chemotherapy for the Treatment of Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Hyunsung Park, MD, Hyunsoo Cho, MD, Jungyeon Lee, MD, Jieun Jang, MD, Yundeok Kim, MD, Soo Jeong Kim, MD, Yu Ri Kim, MD, PhD, Jin Seok Kim, MD, PhD, Yoo Hong Min, MD,PhD, June-Won Cheong, MD, PhD

Blood (2015) 126 (23): 4922.

https://doi.org/10.1182/blood.V126.23.4922.4922

Published: 2015

Journal Articles

NOTCH2 missplicing can occur in relation to apoptosis

In Sik Hwang, Saeam Shin, Yoo Hong Min, Seung-Tae Lee, Jong Rak Choi

Blood (2015) 126 (14): 1731–1732.

https://doi.org/10.1182/blood-2015-07-657825

Published: 2015

Journal Articles

The New Prognostic Model Using Whole Blood Epstein-Barr Virus-DNA Positivity and Low Absolute Lymphocyte Count in Patients with Primary Central Nerve System Lymphoma

Ji Eun Jang, MD, Soo Jeong Kim, MD, June-Won Cheong, MD, PhD, Yun Deok Kim, MD, Yu Ri Kim, MD,PhD, Yoo Hong Min, MD,PhD, Jin Seok Kim, MD, PhD

Blood (2014) 124 (21): 3014.

https://doi.org/10.1182/blood.V124.21.3014.3014

Published: 2014

Journal Articles

Improved Sensitivity and Discriminative Power of Factor FVIII Assay By Applying Turbidimetric Clotting Curve Analysis

Jaewoo Song, MD PhD, Eunyoung Lee, MD, Yula Jeon, MD, Ji Eun Jang, MD, Yundeok Kim, MD, June-Won Cheong, MD, PhD, Yoo Hong Min, MD,PhD

Blood (2014) 124 (21): 2853.

https://doi.org/10.1182/blood.V124.21.2853.2853

Published: 2014

NARROW

Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy

YAP and TAZ in Fibroblastic Reticular Cells Support Hematopoiesis and Retention of Lymphocytes in Lymph Nodes

Peripheral Blood Absolute Lymphocyte Count at Diagnosis As a New Prognostic Factor in Acute Myeloid Leukemia with t(8;21) Patients

Results from a Global Randomized Phase 3 Study of Guadecitabine (G) Vs Treatment Choice (TC) in 815 Patients with Treatment Naïve (TN) AML Unfit for Intensive Chemotherapy (IC) ASTRAL-1 Study: Analysis By Number of Cycles

Progression Free Survival (PFS), and Event Free Survival (EFS) from a Global Randomized Phase 3 Study of Guadecitabine (G) Vs Treatment Choice (TC) in 815 Patients with Treatment Naïve (TN) AML Unfit for Intensive Chemotherapy (IC): ASTRAL-1 Study

Recovery of Specific Subsets of Natural Killer and T Cells Highly Associated with Graft-Versus-Host Disease after Haploidentical Stem Cell Transplantation in Acute Leukemia

Endoplasmic Reticulum Stress Signaling Comprises a G9a Inhibitor Tolerance Pathway and PERK Inhibition Increases Anti-Leukemia Activity of G9a Inhibitor in Leukemia Cells and Leukemia Stem-like Cells

Early CMV Replication-Associated Anti-Leukemia Effect Is Related to the Reconstitution of Specific Subsets of Natural Killer Cells after Haploidentical Stem Cell Transplantation in Acute Leukemia

Inhibition of Unc-51-like Kinase 1 (ULK1) with Novel Small Molecular Inhibitor MRT68921 Preferentially Induces Apoptosis and Autophagy in FLT3-ITD- Mutated Acute Myeloid Leukemia

Clinical and Genetic Relevance of Somatic Mutations in Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) Patients Using Serial Sequencing

Prognostic Impact of Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome

The Clonal Origins of Leukemic Progression of Myelodysplasia

The Role of MYC and BCL-2 Double Expression the in DLBCL Patients with Advanced Stage and Elevated LDH Who Received Upfront ASCT after R-CHOP

Pretreatment Whole Blood Epstein-Barr Viremia Is a Prognostic Factor in Peripheral T-Cell Lymphoma

Risk Factors for Cancer- and Catheter-Associated Thrombosis in Asian Patients with Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy

The Prognostic Role of CD68 and FoxP3 Expression in Primary Central Nervous System Lymphoma

Treatment Choice of Decitabine Versus Conventional Chemotherapy for the Treatment of Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

NOTCH2 missplicing can occur in relation to apoptosis

The New Prognostic Model Using Whole Blood Epstein-Barr Virus-DNA Positivity and Low Absolute Lymphocyte Count in Patients with Primary Central Nerve System Lymphoma

Improved Sensitivity and Discriminative Power of Factor FVIII Assay By Applying Turbidimetric Clotting Curve Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only